Key facts
- Notable investors include HealthQuest Capital, Arsenal Capital Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Neovance
- ·The full record, as it builds
Funding rounds
No funding rounds for Neovance are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neovance
Provider of patient support services intended to streamline access to therapies and improve patient outcomes. The company offers a range of services including integrated care services, non-commercial specialty pharmacy services, field reimbursement services, and nursing services, thereby enabling patients to stay on prescribed therapies more easily.
- Sector
- Healthcare
- HQ
- Raleigh, NC, United States
- Founded
- 1996
- Website
- neovance.com/
- Ownership
- Privately Held (backing)
Neovance doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neovance shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neovance in its N-PORT filings yet. We sweep new filings monthly.